Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is SUCRALFATE USP, with a corresponding US DMF Number 33479.
Remarkably, this DMF maintains an Active status since its submission on January 25, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 08, 2019, and payment made on January 24, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II